Zelnorm Side Effects Lawsuit
The FDA has released a public health advisory concerning Zelnorm alerting doctors and patients of Zelnorm side effects such as Zelnorm heart attack and Zelnorm stroke. If you or a loved one have experienced Zelnorm side effects you may be entitled to compensation. Contact the Zelnorm Lawyers of Ennis & Ennis, P.A. today for a free, confidential case evaluation.
 
Zelnorm Lawsuit
Zelnorm Side Effects Lawsuit
Zelnorm News

Ennis & Ennis, P.A. is representing individuals that have been harmed as a result of Zelnorm side effects. If you or a loved one have suffered from severe chest pain, heart attack or stroke as a result of Zelnorm use you may be entitled to compensation. Click here to contact one of our Zelnorm Attorneys about a Zelnorm lawsuit today.

 

FDA Medication Guide

Zelnorm Heart Attack & Stroke Risks
March 30, 2007 – the Food and Drug Administration (FDA) issued a public health advisory warning the public regarding recent findings that Zelnorm (generic: Tegaserod) significantly increases the risk of adverse cardiac events such as heart attack and stroke. As a result of the increased risk of a Zelnorm heart attack or Zelnorm stroke the FDA requested that Novartis Pharmaceuticals stop marketing Zelnorm. The FDA is currently advising patients who are using Zelnorm to get in touch with their health care providers to discuss treatment alternatives. Patients who are taking Zelnorm should seek emergency medical care if they experience severe chest pain, shortness of breath, dizziness, sudden onset of weakness or difficulty walking or talking, or other symptoms of a heart attack or stroke.

What is Zelnorm?
Zelnorm is a prescription drug approved for short term treatment of women with irritable bowel syndrome with constipation and for patients younger than 65 years with chronic constipation.  

Zelnorm Safety Trials
Safety data from 29 clinical trials involving over 18,000 patients showed that cardiovascular ischemic events occurred in 13 out of 11,614 patients treated with Zelnorm (0.11%), compared with one case in 7,031(0.01%) patients treated with a sugar pill they thought was Zelnorm. All patients affected had pre-existing cardiovascular disease and/or cardiovascular risk factors.

The sponsor of Zelnorm (tegaserod maleate), Novartis Pharmaceuticals Corporation, has agreed to stop selling Zelnorm. 

In its Public Health Advisory, the FDA made the following announcements, effective immediately: 

- Patients being treated with Zelnorm should contact their physician to discuss alternative treatments for their condition.

- Patients who are taking Zelnorm should seek emergency medical care right away if they experience severe chest pain, shortness of breath, dizziness, sudden onset of weakness or difficulty walking or talking or other symptoms of a heart attack or stroke. 

- Physicians who prescribe Zelnorm should work with their patients and transition them to other therapies as appropriate to their symptoms and need.

If you are currently taking Zelnorm and have concerns about its safety, you should consult with your doctor regarding your treatment options. Under no circumstances should you discontinue taking any medication, including Zelnorm, without first consulting with your doctor.

If you or a loved one have experienced Zelnorm side effects such as severe chest pain, heart attack, or stroke you may be entitled to compensation. Contact the Zelnorm attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and attorneys are standing by to answer any questions you may have regarding Zelnorm side effects, a possible Zelnorm class action lawsuit, or any other type of Zelnorm litigation.

08/19/2008- I took Zelnorm over a year ago, until my doctor said the Food and Drug Administration had taken it off the market and it was no longer available. More ::

08/05/2008- If you suffer from allergy symptoms, you could be at risk for developing irritable bowel syndrome. Researchers at Rush University Medical Center in Chicago recently noted that individuals with hay fever are more than twice as likely to have irritable bowel syndrome (IBS) than those who are unaffected by seasonal allergies. More ::

04/05/2008-Having restricted its use last year, Novartis has now served notice that it intends to take its irritable bowel syndrome off the US market completely. The Swiss drugs giant has notified the US Food and Drug Administration that it will no longer provide Zelnorm (tegaserod maleate) as part of a restricted programme agreed with the agency in July last year. That agreement saw Novartis provide the drug to treat IBS with constipation and chronic idiopathic constipation in women younger than 55 who meet certain conditions. More ::

More News>>>
Zelnorm Lawsuit

Offices: Washington DC Office
1101 Pennsylvania Ave.
Suite 600
Washington DC 20004
Telephone: 202-756-2972

Miami Office
1111 Brickell Avenue
11th Floor
Miami, FL 33131
Telephone: 305-913-7199

Fort Lauderdale Office
110 E. Broward Blvd.
Suite 1700
Fort Lauderdale, FL 33301
Telephone: 954-315-3934
Facsimile: 954-315-3914
Free Case Evaluation. Nationwide: 1-800-856-6405